Skip to main content
Clinical Trials/CTRI/2023/08/056002
CTRI/2023/08/056002Not yet recruitingPhase 3

Evaluation of effect of oral melatonin agonist ramelteon for prevention of delirium in adult patients admitted in intensive care unit - Nil

Vardhman Mahavir Medical College And Safdarjung hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.With Preserved ORAL/Enteral intake by the Patient
  • 2.With Richmond Agitation scale(RASS0 score within +2 or -2 during ICU stay

Exclusion Criteria

  • 1.Hemodynamically Unstable or Inotropic Support Patients
  • 2.Patient on Psychotropic Drugs or Known psychiatric illness
  • 3.Patient with debilitating Neurological diseases and Low GCS <10
  • 4. Pregnant Patients

Investigators

Sponsor
Vardhman Mahavir Medical College And Safdarjung hospital

Similar Trials

Assessing the role of oral melatonin... | Clinical Trial